Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Protea and Proteos Announce Co-Marketing Agreement

Friday, May 05, 2017

Protea Biosciences Group Inc and Proteos Inc announced that they have entered into a joint comarketing agreement This mutual partnership allows Protea to combine Proteos protein production capabilities alongside Proteas proprietary bioanalytical serv...

Quivive Pharma Partners with Camargo Pharmaceutical Services for Development Programs

Friday, May 05, 2017

Quivive Pharma a San Diegobased biotechnology company developing next generation opioid therapies announced today that it has entered into service agreements with Camargo Pharmaceutical Services LLC Camargo will be providing regulatory consulting and...

Cannabics Pharmaceuticals Announces Scientific Collaboration With A Leading CTC European Lab

Thursday, May 04, 2017

Cannabics Pharmaceuticals Inc announced it has begun a scientific collaboration with a medical laboratory in Europe a world leader in the field of CTC circulating tumor cells count and drug sensitivity tests for cancer patients The company wishes...

CARsgen Therapeutics Opens CAR T-cell Manufacturing Facility in Shanghai

Thursday, May 04, 2017

CARsgen Therapeutics a global leader in developing chimeric antigen receptor Tcell CART cell therapies for solid tumors has announced the opening of its new manufacturing facility in Shanghai The facility features stateofart capabilities to manufa...

Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears™

Wednesday, May 03, 2017

Imprimis Pharmaceuticals Inc an ophthalmologyfocused pharmaceutical company and SightLife Surgical a corneafocused organization providing comprehensive services to ophthalmic surgeons announced the signing of an exclusive strategic sales and marketin...

Aries Pharmaceuticals, Inc. Launches Eleview™ for use in Gastrointestinal Endoscopic Procedures

Wednesday, May 03, 2017

Aries Pharmaceuticals Inc today announced the launch and commercial availability of its first product Eleview a novel ready to use submucosal injectable composition for use in the easy and safe endoscopic removal of polyps adenomas and early stage ca...

GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD

Tuesday, May 02, 2017

GSK announced million of new investment in its biopharmaceutical manufacturing site in Rockville MD to support growing demand for BENLYSTA belimumab for adult patients with active autoantibodypositive systemic lupus erythematosus SLE who are receivi...

Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications

Tuesday, May 02, 2017

Shire plc and Parion Sciences Inc announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P Shire will lead development of P an investigational epithelial sodium channel ENaC inhibitor for...

NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer's Disease

Monday, May 01, 2017

Neurotrope Inc today announced positive topline results from its Phase study Study of Bryostatin in patients with moderate to severe Alzheimers disease AD a population not commonly targeted in AD clinical trials Bryostatin a Protein Kinase C epsilo...

Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)

Saturday, April 29, 2017

Takeda Pharmaceutical Company Limited announced that ALUNBRIG brigatinib has received Accelerated Approval from the US Food and Drug Administration FDA for the treatment of patients with anaplastic lymphoma kinasepositive ALK metastatic nonsmall cell...